Team (TISI) Q2 2025 Earnings Call Transcript

Adjusted EBITDA rose 12.4% to $24.5M while revenue increased 8.5% (nearly $20M) with consolidated gross margin improving (reported 27.5% and described as up 7.1% year-over-year); consolidated adjusted EBITDA margin widened 40 bps to 9.9%. Inspection & Heat Treating revenue grew 15% (U.S. +13%, Canada +31%) with IHT adjusted EBITDA margin up 118 bps aided by a ~26% increase in higher‑margin heat‑treating revenue; Mechanical Services revenue was up 2% with U.S. +7%. Balance sheet and liquidity strengthened (cash $16.6M + $32.7M undrawn = $49M) after a March 2025 refinancing that cut blended interest >100 bps and extended term loans to 2030; management targets ~$10M annualized cost savings (~$6M in H2 2025) and reiterated at least 15% full‑year adjusted EBITDA growth and progress toward a 10%+ adjusted EBITDA margin.

Analysis

Management’s recent actions materially change the optionality of the business: the balance-sheet repairs and runway allow the company to prioritize structural margin work (pricing, utilization, higher‑margin service mix) over near‑term survival. That raises the probability that margin expansion is persistent rather than cyclical — especially if heat‑treating and NDE cross‑sell convert more projects into recurring, contracted work.

Canadian and specialized service wins are a leading indicator, not the full story: outperformance in a small geography often signals playbook transferability (pricing discipline, field productivity, regional leadership) that can be replicated in larger U.S. markets, but only if workforce utilization and scheduling constraints are resolved. The key operational lever to watch is throughput per technician (jobs per week) and booked backlog quality — those will determine whether higher margins stick or re‑leak into SG&A.

Tariff and supply‑chain noise is the wildcard; an adverse tariff shock would raise input costs and could shift customers to onshore service providers (a potential demand tailwind) while simultaneously compressing margins if contracts are fixed. Execution risk on transformation — timing, union/workforce frictions, and one‑time severance versus recurring savings — is the biggest near‑term downside. Monitor quarterly cadence of realized run‑rate savings, backlog composition (contracted vs spot), and gross margin on heat‑treating/inspection to adjudicate the thesis.

Key Decisions for Investors

• TISI — 9–12 month long equity (size 2–4% NAV). Thesis: buy the idiosyncratic leverage to margin improvement and cleaner capital structure; trim/rehab if realized margin trajectory stalls. Risk management: hard stop at 20–25% drawdown; target asymmetric upside of 40–80% if adjusted EBITDA margin crosses the 10%+ inflection and multiple re-rates.
• TISI — 9–12 month call‑spread (buy 1yr call, sell higher strike) for lower-cost upside exposure if you prefer defined risk. Rationale: captures multiple expansion without full equity volatility; max loss = premium paid, upside = difference between strikes minus premium. Use if you expect visible H2 cadence of realized savings.
• Pair trade — Long TISI / Short XLI (equal dollar) for 6–12 months to isolate company‑specific operational improvement vs broad industrial cyclicality. Reward: captures idiosyncratic margin improvement while hedging commodity/cycle risk; risk: sector underperformance while company execution fails — size at 1–2% NAV net exposure.
• Event hedge — Buy short‑dated puts on TISI (3–6 months) ahead of next two quarterly prints if you hold a long position; cost justified as insurance against execution/tariff disappointment that could wipe out near‑term earnings beats.